Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Priority to DO2002000527ApriorityCriticalpatent/DOP2002000527A/es
Publication of DOP2002000527ApublicationCriticalpatent/DOP2002000527A/es
La presente invencion se refiere a una cristalina de 6-[(2,2-difenilletil)amino]-9-(n-etil-b-d-5 ribofuranossiluronamida)-n-(2-{n'-[1-(2-piridil)-4-piperidil]ureido}etil)-9h-purin-2-carboxamida y a un procedimiento para la presentación de la misma, a composiciones que la contienen y a los usos de dicha forma cristalina.
DO2002000527A2002-11-272002-11-27Forma de farmaco cristalina.
DOP2002000527A
(es)
Formas cristalinas y otras formas de las sales de ácido láctico de 4-amino-5-fluoro-3-[6-(4-metilpiperazin -1-il)-1h-bencimidazol-2 -il]-1h-quinolin-2-ona
Krystallinske former av 1'-(1-metyl)-4'-[(2-fluor-4-metoksyfenyl)metyl]-5'-metyl-1H-pyrazol-3'-O-beta-D-glucopyranosid, en fremstillingsmetode og anvendelse av denne for fremstilling av medikamenter
3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridine-2-yl-amino]-propionic acid ethyl ester methane sulphonate and use thereof as a medicament
compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, sua utilização e método para o tratamento e/ou profilaxia de enfermidades
Proceso de preparacion de sales de 4-[[5-[(ciclopropilamino)carbonil]-2-metilfenil]amino]-5-metil-n- propilpirrolo[2,1,f][1,2,4]triazin-6-carboxamida y formas cristalinas estables de dichas sales